| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |